Royalty Pharma
RPRX
#621
Rank
$39.49 B
Marketcap
$68.68
Share price
0.23%
Change (1 day)
75.38%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): $1.53

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is $1.53. In 2025 the company made an earnings per share (EPS) of $1.79 a decrease over its 2024 EPS that were of $1.93.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$1.53-14.53%
2025$1.79-7.1%
2024$1.93
2020$1.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
$2.70 76.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$30.89 1,920.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$5.18 238.73%๐Ÿ‡บ๐Ÿ‡ธ USA